Bettapharma
Bettapharma mainly providing customers with products such as Ectinib hydrochlorid
Beda Pharmaceuticals is an innovative drug developer in the fields of malignancy, ophthalmology, autoimmune diseases and diabetes, mainly providing customers with products such as Ectinib hydrochloride (Kemena), new antineoplastic drug CM082 and other products, including six national Class I and Class II new drugs, and 14 national Class III and Class IV new drugs in the pipeline.
Boten Co., Ltd.: direnavir API has passed who PQ certification
TECO shares: obtained an invention patent certificate
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
The first bank of China fund to release its second Quarterly Report
Beida pharmaceutical: the three shareholders intend to reduce the shares of the company no more than 2.31%